All Articles

Browse the full archive, newest first.

Telix Pharmaceuticals Initiates Phase 3 Trial for Brain Cancer Treatment

Telix Pharmaceuticals has commenced a significant Phase 3 trial aimed at evaluating a new therapy for brain cancer, marking a crucial step in their research efforts.

Editorial Staff Apr 19

Money

Zai Lab and Amgen Collaborate on Lung Cancer Therapy Evaluation

Zai Lab and Amgen have announced a partnership to evaluate a new approach to lung cancer treatment, marking a significant step in cancer research.

Editorial Staff Apr 19

Money

Calumet Completes $150 Million Senior Notes Private Placement

Calumet (CLMT) has finalized a private placement of senior notes, raising $150 million to support its financial strategy.

Editorial Staff Apr 19

Money

Ultragenyx's Gene Therapy for Sanfilippo Syndrome Receives FDA Acceptance

The FDA has accepted Ultragenyx's Biologics License Application for its gene therapy UX111, aimed at treating Sanfilippo Syndrome.

Editorial Staff Apr 19

Money

Evaluating Sigma Lithium's Valuation Amid New Financing and Production Projections

An overview of Sigma Lithium's recent financing achievements and production forecasts, highlighting its growth potential.

Editorial Staff Apr 19

Money

Exploring Underrated Growth Stocks: GitLab Among Ten Picks

A new analysis highlights ten growth stocks, including GitLab, that investors may want to consider as they remain relatively unnoticed in the market.

Editorial Staff Apr 19

Money

Exploring the Potential of Travere (TVTX) as a Growth Investment

Travere (TVTX) has been identified as a potential growth stock that may be overlooked by many investors. Here’s a closer look at its investment prospects.

Editorial Staff Apr 19

Money

Exploring the Potential of Legend Biotech as a Growth Stock

A closer look at Legend Biotech's status as a potential growth stock amid current market conditions.

Editorial Staff Apr 19

Life

New Optical Meta-Spanners Revolutionize Light Manipulation Techniques

A recent advancement in optical technology offers the ability to control microscopic matter with unprecedented precision, allowing for customized movement along various paths.

Editorial Staff Apr 19

Life

Study Reveals Significant Weakening of Atlantic Current Over Past Two Decades

Recent research published in Science Advances indicates a notable decline in the Atlantic Meridional Overturning Circulation (AMOC) across four deep-ocean monitoring sites over the last twenty years.

Editorial Staff Apr 19